BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27668377)

  • 1. Development and Evaluation of a Lung Cancer Screening Decision Aid.
    Hart K; Tofthagen C; Wang HL
    Clin J Oncol Nurs; 2016 Oct; 20(5):557-9. PubMed ID: 27668377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung Cancer Screening Benefits and Harms Stratified by Patient Risk: Information to Improve Patient Decision Aids.
    Bellinger C; Pinsky P; Foley K; Case D; Dharod A; Miller D
    Ann Am Thorac Soc; 2019 Apr; 16(4):512-514. PubMed ID: 30620619
    [No Abstract]   [Full Text] [Related]  

  • 3. Patients' Attitudes Regarding Lung Cancer Screening and Decision Aids. A Survey and Focus Group Study.
    Crothers K; Kross EK; Reisch LM; Shahrir S; Slatore C; Zeliadt SB; Triplette M; Meza R; Elmore JG
    Ann Am Thorac Soc; 2016 Nov; 13(11):1992-2001. PubMed ID: 27652509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a Personalized, Web-Based Decision Aid for Lung Cancer Screening.
    Lau YK; Caverly TJ; Cao P; Cherng ST; West M; Gaber C; Arenberg D; Meza R
    Am J Prev Med; 2015 Dec; 49(6):e125-9. PubMed ID: 26456873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing and testing a brief clinic-based lung cancer screening decision aid for primary care settings.
    McDonnell KK; Strayer SM; Sercy E; Campbell C; Friedman DB; Cartmell KB; Eberth JM
    Health Expect; 2018 Aug; 21(4):796-804. PubMed ID: 29473696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of a patient decision aid about lung cancer screening with low-dose computed tomography.
    Volk RJ; Linder SK; Leal VB; Rabius V; Cinciripini PM; Kamath GR; Munden RF; Bevers TB
    Prev Med; 2014 May; 62():60-3. PubMed ID: 24518006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-Care Spirometry Identifies High-Risk Individuals Excluded from Lung Cancer Screening.
    Lam ACL; Aggarwal R; Huang J; Varadi R; Davis L; Tsao MS; Shepherd FA; Lam S; Kavanagh J; Liu G
    Am J Respir Crit Care Med; 2020 Nov; 202(10):1473-1477. PubMed ID: 32673057
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of novel biological tools used in screening for the early detection of lung cancer.
    Ghosal R; Kloer P; Lewis KE
    Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to Lung Cancer Screening With Low-Dose Computed Tomography.
    Lei F; Lee E
    Oncol Nurs Forum; 2019 Mar; 46(2):E60-E71. PubMed ID: 30767965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection and screening of lung cancer.
    Mascaux C; Peled N; Garg K; Kato Y; Wynes MW; Hirsch FR
    Expert Rev Mol Diagn; 2010 Sep; 10(6):799-815. PubMed ID: 20843203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer screening gets risk-specific.
    Peres J
    J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155
    [No Abstract]   [Full Text] [Related]  

  • 13. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
    Li K; Hüsing A; Sookthai D; Bergmann M; Boeing H; Becker N; Kaaks R
    Cancer Prev Res (Phila); 2015 Sep; 8(9):777-85. PubMed ID: 26076698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summaries for patients. Screening for lung cancer: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2014 Mar; 160(5):I-40. PubMed ID: 24378963
    [No Abstract]   [Full Text] [Related]  

  • 15. The Prevalence of Obstructive Lung Disease in a Lung Cancer Screening Cohort: Analysis of the National Lung Screening Trial-American College of Radiology Image Network Cohort.
    de-Torres JP; Wisnivesky JP; Bastarrika G; Wilson DO; Celli BR; Zulueta JJ
    Ann Am Thorac Soc; 2019 May; 16(5):641-644. PubMed ID: 30673510
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for lung cancer.
    Ngo-Metzger Q; Fan T
    Am Fam Physician; 2014 Jul; 90(2):117-8. PubMed ID: 25077586
    [No Abstract]   [Full Text] [Related]  

  • 17. Balancing the benefits and harms of low-dose computed tomography screening for lung cancer: Medicare's options for coverage.
    Wiener RS
    Ann Intern Med; 2014 Sep; 161(6):445-6. PubMed ID: 24957566
    [No Abstract]   [Full Text] [Related]  

  • 18. Off the mark: Current lung cancer screening guidelines miss those most at risk.
    Printz C
    Cancer; 2015 Aug; 121(15):2477-8. PubMed ID: 26198788
    [No Abstract]   [Full Text] [Related]  

  • 19. Lung cancer screening and management.
    Jones GS; Baldwin DR
    Minerva Med; 2015 Dec; 106(6):339-54. PubMed ID: 26605556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
    Pinsky PF; Berg CD
    J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.